Skip to main content
Clinical Trials/JPRN-jRCTs031210135
JPRN-jRCTs031210135
Recruiting
未知

Significance of ICG fluorescence-guided navigation laparoscopic surgery for gastric and esophagogastric junction cancer

Sano Akihiko0 sites150 target enrollmentJune 9, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Gastric cancer, Esophagogastric junction cancer
Sponsor
Sano Akihiko
Enrollment
150
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 9, 2021
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Sano Akihiko

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients with resectable gastric and esophagogastric junction cancer who have pathologically diagnosed of adenocarcinoma.
  • 2\. 20\-years old and more, PS 0\-2\. Gender does not matter.
  • 3\. Consent to participate in the study and the patient or his / her representative has signed the ethics committee approval consent document.

Exclusion Criteria

  • 1\. Patients with active double cancer (simultaneous double cancer and metachronous double cancer with a disease\-free period of up to 5 years).
  • 2\. Patients with a history of frequent laparotomy and expected to have a high degree of intra\-abdominal adhesions.
  • 3\. Patients with a history of ICG or iodine hypersensitivity, asthma or severe drug allergies.
  • 4\. Patients with serious comorbidities.
  • 5\. Female patients of childbearing potential or breastfeeding.
  • 6\. Patients receiving continuous systemic steroids (oral or intravenous).
  • 7\. Patients with mental illness or psychiatric symptoms who are judged to be difficult to participate.
  • 8\. In addition, patients who are judged by the principal investigator to be inappropriate for participation in this study.

Outcomes

Primary Outcomes

Not specified

Similar Trials